Sumitomo Pharma Co., Ltd. (DNPUF) Discusses R&D Progress, Oncology Pipeline, and Advances in Regenerative Medicine and Vaccines Transcript

R&D Meeting Overview - The R&D meeting of Sumitomo Pharma Company Limited is being conducted to discuss R&D progress, basic policy, and two major oncology products [1] - The meeting is scheduled to conclude at 15:40 [1] Attendees - Key attendees include Mr. Kimura (Representative Director, President and CEO), Mr. Sakai (Representative Director, Executive Vice President), Ms. Sato (Managing Executive Officer), and Mr. Murata (Global Strategy Oncology Lead) [2] - Mr. Kimura is expected to provide introductory remarks [2]